[Federal Register Volume 65, Number 75 (Tuesday, April 18, 2000)]
[Notices]
[Pages 20825-20826]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-9580]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. 79N-0113; DESI 2847]


Pediatric Parenteral Multivitamin Products; Drug Efficacy Study 
Implementation; Announcement of Marketing Conditions; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
that appeared in the Federal Register of January 26, 2000 (65 FR 4253). 
The document announced the conditions for marketing pediatric 
parenteral multivitamin drug products for the indications for which 
they are

[[Page 20826]]

now regarded as effective. The document was published with an 
inadvertent error. This document corrects that error.

FOR FURTHER INFORMATION CONTACT: Mary E. Catchings, Center for Drug 
Evaluation and Research (HFD-7), Food and Drug Administration, 5600 
Fishers Lane, Rockville, MD 20857, 301-594-2041.

SUPPLEMENTARY INFORMATION: In FR Doc. 00-1787 appearing on page 4253 in 
the Federal Register of Wednesday, January 26, 2000, the following 
correction is made:
    On page 4255, in the first column, in paragraph B.2.(a), beginning 
in the second line, the sentence ``Caution: Federal law prohibits 
dispensing without prescription'' is corrected to read ``Rx only.''
    This change is made in accordance with section 126(a) of the Food 
and Drug Modernization Act of 1997. Section 126(a) modified section 
503(b)(4) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 
353(b)(4)).

    Dated: April 7, 2000.
William K. Hubbard,
Senior Associate Commissioner for Policy, Planning, and Legislation.
[FR Doc. 00-9580 Filed 4-17-00; 8:45 am]
BILLING CODE 4160-01-F